<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT01666912</url>
  </required_header>
  <id_info>
    <org_study_id>PPI-12-0732</org_study_id>
    <nct_id>NCT01666912</nct_id>
  </id_info>
  <brief_title>Postpartum Etonogestrel Implant for Adolescents</brief_title>
  <acronym>PPImplant</acronym>
  <official_title>Etonogestrel-releasing Subdermal Implant for Adolescents in the Postpartum Period: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective study comparing two groups of 48 adolescent women each. The&#xD;
      intervention group will receive a contraceptive implant postpartum, prior to discharge from&#xD;
      the hospital. The control group will receive a contraceptive implant at the usual 6 week&#xD;
      postpartum clinic visit. During prenatal care, participants will be consented and screened&#xD;
      for enrollment. After delivery, these women will be assessed and consented for enrollment&#xD;
      into the study. Women who consent for enrollment will be randomized. Women will be followed&#xD;
      up at 3 months, 6 months, 9 months, and 1 year after contraceptive implant insertion. At each&#xD;
      follow up, women will be assessed for continuation of and satisfaction with this method of&#xD;
      contraception.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Continuation at 1 Year</measure>
    <time_frame>12-14 months</time_frame>
    <description>The number of participants using the contraceptive implant at one year postpartum among women who have the implant placed immediately postpartum vs. at 6 weeks postpartum.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction</measure>
    <time_frame>12 months</time_frame>
    <description>To assess satisfaction with the contraceptive implant inserted in the postpartum period, using a scale of 0-10, with 0 being &quot;not satisfied at all&quot; to 10 being &quot;extremely satisfied.&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rapid Repeat Pregnancy</measure>
    <time_frame>12 months</time_frame>
    <description>To assess rapid repeat pregnancies among the study population, ie, the number of participants who reported a repeat pregnancy within 12 months postpartum.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Adolescence</condition>
  <condition>Contraception</condition>
  <condition>Postpartum</condition>
  <arm_group>
    <arm_group_label>6 week postpartum contraceptive implant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>randomized to receive contraceptive implant at normal 6 week postpartum visit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Immediate postpartum contraceptive implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>randomized to receive contraceptive implant prior to leaving the hospital postpartum</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Contraceptive implant</intervention_name>
    <arm_group_label>6 week postpartum contraceptive implant</arm_group_label>
    <arm_group_label>Immediate postpartum contraceptive implant</arm_group_label>
    <other_name>Implanon, Nexplanon, etonogestrel contraceptive implant</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adolescents ages 14-24 attending prenatal care&#xD;
&#xD;
          -  Greater than 20 weeks estimated gestational age&#xD;
&#xD;
          -  English or Spanish-speaking&#xD;
&#xD;
          -  Desire to use the contraceptive implant for contraception postpartum&#xD;
&#xD;
          -  Anticipated delivery of a healthy infant vaginally or by cesarean.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Participants will not be eligible for participation if they have any contraindications to&#xD;
        contraceptive implant use, including&#xD;
&#xD;
          -  current or past history of thrombosis or thromboembolic disorders&#xD;
&#xD;
          -  hepatic tumors (benign or malignant)&#xD;
&#xD;
          -  active liver disease&#xD;
&#xD;
          -  undiagnosed abnormal genital bleeding&#xD;
&#xD;
          -  known or suspected carcinoma of the breast (or a personal history of breast cancer)&#xD;
&#xD;
          -  hypersensitivity to any of the components of the contraceptive implant.&#xD;
&#xD;
          -  Current use of any medications known to induce hepatic enzymes, including but not&#xD;
             limited to: barbiturates, bosentan, carbamazepine, felbamate, griseofulvin,&#xD;
             oxcarbazepine, phenytoin, rifampin, St. John's wort, or topiramate&#xD;
&#xD;
        Characteristics that would preclude involvement after delivery:&#xD;
&#xD;
          -  Birth of a stillborn infant.&#xD;
&#xD;
          -  Maternal ICU admission after delivery&#xD;
&#xD;
          -  Maternal postpartum hemorrhage requiring blood transfusion&#xD;
&#xD;
          -  Prolonged hospital stay (&gt;7 days) postpartum&#xD;
&#xD;
          -  Coagulopathy associated with the pregnancy&#xD;
&#xD;
          -  Severe pregnancy-induced hypertension&#xD;
&#xD;
          -  Fever &gt;38 degrees C postpartum&#xD;
&#xD;
          -  Adolescent women who are not competent to consent, secondary to stress from the labor&#xD;
             process, for example severe pain or sleep deprivation, will not be offered enrolment&#xD;
             into the trial&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of North Carolina Hospitals</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27514</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <study_first_submitted>August 14, 2012</study_first_submitted>
  <study_first_submitted_qc>August 14, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2012</study_first_posted>
  <results_first_submitted>January 13, 2017</results_first_submitted>
  <results_first_submitted_qc>March 20, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 1, 2017</results_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of North Carolina, Chapel Hill</investigator_affiliation>
    <investigator_full_name>Amy Bryant</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>adolescence</keyword>
  <keyword>contraception</keyword>
  <keyword>postpartum</keyword>
  <keyword>rapid repeat pregnancy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contraceptive Agents</mesh_term>
    <mesh_term>Etonogestrel</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>6 Week Postpartum Contraceptive Implant</title>
          <description>randomized to receive contraceptive implant at normal 6 week postpartum visit&#xD;
Contraceptive implant</description>
        </group>
        <group group_id="P2">
          <title>Immediate Postpartum Contraceptive Implant</title>
          <description>randomized to receive contraceptive implant prior to leaving the hospital postpartum&#xD;
Contraceptive implant</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>6 Week Postpartum Contraceptive Implant</title>
          <description>randomized to receive contraceptive implant at normal 6 week postpartum visit&#xD;
Contraceptive implant</description>
        </group>
        <group group_id="B2">
          <title>Immediate Postpartum Contraceptive Implant</title>
          <description>randomized to receive contraceptive implant prior to leaving the hospital postpartum&#xD;
Contraceptive implant</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="48"/>
            <count group_id="B2" value="48"/>
            <count group_id="B3" value="96"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21" spread="2.58"/>
                    <measurement group_id="B2" value="21" spread="2.35"/>
                    <measurement group_id="B3" value="21" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="96"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Continuation at 1 Year</title>
        <description>The number of participants using the contraceptive implant at one year postpartum among women who have the implant placed immediately postpartum vs. at 6 weeks postpartum.</description>
        <time_frame>12-14 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>6 Week Postpartum Contraceptive Implant</title>
            <description>randomized to receive contraceptive implant at normal 6 week postpartum visit&#xD;
Contraceptive implant</description>
          </group>
          <group group_id="O2">
            <title>Immediate Postpartum Contraceptive Implant</title>
            <description>randomized to receive contraceptive implant prior to leaving the hospital postpartum&#xD;
Contraceptive implant</description>
          </group>
        </group_list>
        <measure>
          <title>Continuation at 1 Year</title>
          <description>The number of participants using the contraceptive implant at one year postpartum among women who have the implant placed immediately postpartum vs. at 6 weeks postpartum.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction</title>
        <description>To assess satisfaction with the contraceptive implant inserted in the postpartum period, using a scale of 0-10, with 0 being &quot;not satisfied at all&quot; to 10 being &quot;extremely satisfied.&quot;</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>6 Week Postpartum Contraceptive Implant</title>
            <description>randomized to receive contraceptive implant at normal 6 week postpartum visit&#xD;
Contraceptive implant</description>
          </group>
          <group group_id="O2">
            <title>Immediate Postpartum Contraceptive Implant</title>
            <description>randomized to receive contraceptive implant prior to leaving the hospital postpartum&#xD;
Contraceptive implant</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction</title>
          <description>To assess satisfaction with the contraceptive implant inserted in the postpartum period, using a scale of 0-10, with 0 being &quot;not satisfied at all&quot; to 10 being &quot;extremely satisfied.&quot;</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.68" spread="1.36"/>
                    <measurement group_id="O2" value="8.29" spread="2.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rapid Repeat Pregnancy</title>
        <description>To assess rapid repeat pregnancies among the study population, ie, the number of participants who reported a repeat pregnancy within 12 months postpartum.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>6 Week Postpartum Contraceptive Implant</title>
            <description>randomized to receive contraceptive implant at normal 6 week postpartum visit&#xD;
Contraceptive implant</description>
          </group>
          <group group_id="O2">
            <title>Immediate Postpartum Contraceptive Implant</title>
            <description>randomized to receive contraceptive implant prior to leaving the hospital postpartum&#xD;
Contraceptive implant</description>
          </group>
        </group_list>
        <measure>
          <title>Rapid Repeat Pregnancy</title>
          <description>To assess rapid repeat pregnancies among the study population, ie, the number of participants who reported a repeat pregnancy within 12 months postpartum.</description>
          <units>participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="1" upper_limit="5"/>
                    <measurement group_id="O2" value="5" lower_limit="4" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>6 Week Postpartum Contraceptive Implant</title>
          <description>randomized to receive contraceptive implant at normal 6 week postpartum visit&#xD;
Contraceptive implant</description>
        </group>
        <group group_id="E2">
          <title>Immediate Postpartum Contraceptive Implant</title>
          <description>randomized to receive contraceptive implant prior to leaving the hospital postpartum&#xD;
Contraceptive implant</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Amy G. Bryant, Assistant Professor</name_or_title>
      <organization>UNC_ChapelHill</organization>
      <phone>919-843-5633</phone>
      <email>amy_bryant@med.unc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT01666912
org study id: PPI-12-0732
nct id: NCT01666912
lead sponsor: 
has dmc: Yes
This is a prospective study comparing two groups of 48 adolescent women each. The
      intervention group will receive a contraceptive implant postpartum, prior to discharge from
      the hospital. The control group will receive a contraceptive implant at the usual 6 week
      postpartum clinic visit. During prenatal care, participants will be consented and screened
      for enrollment. After delivery, these women will be assessed and consented for enrollment
      into the study. Women who consent for enrollment will be randomized. Women will be followed
      up at 3 months, 6 months, 9 months, and 1 year after contraceptive implant insertion. At each
      follow up, women will be assessed for continuation of and satisfaction with this method of
      contraception.
allocation: Randomized
intervention model: Parallel Assignment
primary purpose: Prevention
masking: None (Open Label)
measure: Continuation at 1 Year
time frame: 12-14 months
description: The number of participants using the contraceptive implant at one year postpartum among women who have the implant placed immediately postpartum vs. at 6 weeks postpartum.
measure: Satisfaction
time frame: 12 months
description: To assess satisfaction with the contraceptive implant inserted in the postpartum period, using a scale of 0-10, with 0 being "not satisfied at all" to 10 being "extremely satisfied."
measure: Rapid Repeat Pregnancy
time frame: 12 months
description: To assess rapid repeat pregnancies among the study population, ie, the number of participants who reported a repeat pregnancy within 12 months postpartum.
arm group label: 6 week postpartum contraceptive implant
arm group type: Active Comparator
description: randomized to receive contraceptive implant at normal 6 week postpartum visit
arm group label: Immediate postpartum contraceptive implant
arm group type: Experimental
description: randomized to receive contraceptive implant prior to leaving the hospital postpartum
intervention type: Drug
intervention name: Contraceptive implant
arm group label: 6 week postpartum contraceptive implant
arm group label: Immediate postpartum contraceptive implant
other name: Implanon, Nexplanon, etonogestrel contraceptive implant
criteria: 
gender: Female
minimum age: 14 Years
maximum age: 24 Years
healthy volunteers: Accepts Healthy Volunteers
facility: 
country: United States
responsible party type: Principal Investigator
investigator affiliation: University of North Carolina, Chapel Hill
investigator full name: Amy Bryant
investigator title: Assistant Professor
mesh term: Contraceptive Agents
mesh term: Etonogestrel
participant flow: 
baseline: 
outcome list: 
reported events: 
certain agreements: 
point of contact: 